APO Research
Talk to an analyst

APO RESEARCH · REPORT

Mycoplasma Testing in Clinical

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Mycoplasma Testing in Clinical Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

5 June 2026197 pages

Choose your research edition.

Industry ResearchMycoplasma Testing in Clinical Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Mycoplasma Testing in Clinical Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Mycoplasma Testing in Clinical Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Mycoplasma Testing in Clinical Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Mycoplasma Testing in Clinical Market Analysis and Forecast 2026-2032181 pages · $4,950 USD

Market perspective

The global Mycoplasma Testing in Clinical market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Mycoplasma Testing in Clinical is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Mycoplasma Testing in Clinical is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Mycoplasma Testing in Clinical is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Mycoplasma Testing in Clinical is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Mycoplasma Testing in Clinical include Charles River Laboratories International, Thermo Fisher Scientific, SGS, Bionique Testing Laboratories, WuXi AppTec, Labcorp, IDEXX BioAnalytics, WiCell and Creative Biogene, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Mycoplasma Testing in Clinical market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Mycoplasma Testing in Clinical and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Mycoplasma Testing in Clinical revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Mycoplasma Testing in Clinical market size, projected growth trends, production technologies, key applications, and end-use industries.

Mycoplasma Testing in Clinical Segment by Company

Charles River Laboratories International

Thermo Fisher Scientific

SGS

Bionique Testing Laboratories

WuXi AppTec

Labcorp

IDEXX BioAnalytics

WiCell

Creative Biogene

Eurofins Scientific

Hylabs

JOINN Laboratories

Shimadzu Diagnostics

CellSafe

FullHope Biomedical

Syngene International

Beyotime

CTI Cert

Shenke Bio

Mycoplasma Testing in Clinical Segment by Type

Culture-based Mycoplasma Detection

PCR/qPCR Mycoplasma Detection

Others

Mycoplasma Testing in Clinical Segment by Application

Hospitals

Clinical Laboratories

Public Health Institutions

Third-Party Medical Testing Centers

Others

Mycoplasma Testing in Clinical Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mycoplasma Testing in Clinical market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mycoplasma Testing in Clinical and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mycoplasma Testing in Clinical.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Mycoplasma Testing in Clinical in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Mycoplasma Testing in Clinical industry.

Chapter 3: Detailed analysis of Mycoplasma Testing in Clinical companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Mycoplasma Testing in Clinicalrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Mycoplasma Testing in Clinical Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Culture-based Mycoplasma Detection Table 3. Key Players of PCR/qPCR Mycoplasma Detection Table 4. Key Players of Others Table 4. Global Mycoplasma Testing in Clinical Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospitals Table 6. Key Players of Clinical Laboratories Table 7. Key Players of Public Health Institutions Table 8. Key Players of Third-Party Medical Testing Centers Table 9. Key Players of Others Table 10. Global Mycoplasma Testing in Clinical Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 11. Global Mycoplasma Testing in Clinical Market Size by Region (2021-2026) & (US$ Million) Table 12. Global Mycoplasma Testing in Clinical Market Share by Region (2021-2026) Table 13. Global Mycoplasma Testing in Clinical Market Size by Region (2027-2032) & (US$ Million) Table 14. Global Mycoplasma Testing in Clinical Market Share by Region (2027-2032) Table 15. Mycoplasma Testing in Clinical Industry Trends Table 16. Mycoplasma Testing in Clinical Industry Drivers Table 17. Mycoplasma Testing in Clinical Industry Opportunities and Challenges Table 18. Mycoplasma Testing in Clinical Industry Restraints Table 19. Global Mycoplasma Testing in Clinical Revenue by Company (US$ Million) & (2021-2026) Table 20. Global Mycoplasma Testing in Clinical Revenue Market Share by Company (2021-2026) Table 21. Global Mycoplasma Testing in Clinical Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 22. Global Mycoplasma Testing in Clinical Key Company Head Office and Area Served Table 23. Global Mycoplasma Testing in Clinical Company, Product Type & Application Table 24. Global Mycoplasma Testing in Clinical Company Establishment Date Table 25. Global Company Market Concentration Ratio (CR5 and HHI) Table 26. Global Mycoplasma Testing in Clinical by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 27. Global Mycoplasma Testing in Clinical Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Mycoplasma Testing in Clinical Market Size by Type (2021-2026) & (US$ Million) Table 29. Global Mycoplasma Testing in Clinical Market Size by Type (2027-2032) & (US$ Million) Table 30. Global Mycoplasma Testing in Clinical Revenue Market Share by Type (2021-2026) Table 31. Global Mycoplasma Testing in Clinical Revenue Market Share by Type (2027-2032) Table 32. Global Mycoplasma Testing in Clinical Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Mycoplasma Testing in Clinical Market Size by Application (2021-2026) & (US$ Million) Table 34. Global Mycoplasma Testing in Clinical Market Size by Application (2027-2032) & (US$ Million) Table 35. Global Mycoplasma Testing in Clinical Revenue Market Share by Application (2021-2026) Table 36. Global Mycoplasma Testing in Clinical Revenue Market Share by Application (2027-2032) Table 37. Charles River Laboratories International Company Information Table 38. Charles River Laboratories International Business Overview Table 39. Charles River Laboratories International Mycoplasma Testing in Clinical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Charles River Laboratories International Mycoplasma Testing in Clinical Product Portfolio Table 41. Charles River Laboratories International Recent Development Table 42. Thermo Fisher Scientific Company Information Table 43. Thermo Fisher Scientific Business Overview Table 44. Thermo Fisher Scientific Mycoplasma Testing in Clinical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Thermo Fisher Scientific Mycoplasma Testing in Clinical Product Portfolio Table 46. Thermo Fisher Scientific Recent Development Table 47. SGS Company Information Table 48. SGS Business Overview Table 49. SGS Mycoplasma Testing in Clinical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. SGS Mycoplasma Testing in Clinical Product Portfolio Table 51. SGS Recent Development Table 52. Bionique Testing Laboratories Company Information Table 53. Bionique Testing Laboratories Business Overview Table 54. Bionique Testing Laboratories Mycoplasma Testing in Clinical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Bionique Testing Laboratories Mycoplasma Testing in Clinical Product Portfolio Table 56. Bionique Testing Laboratories Recent Development Table 57. WuXi AppTec Company Information Table 58. WuXi AppTec Business Overview Table 59. WuXi AppTec Mycoplasma Testing in Clinical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. WuXi AppTec Mycoplasma Testing in Clinical Product Portfolio Table 61. WuXi AppTec Recent Development Table 62. Labcorp Company Information Table 63. Labcorp Business Overview Table 64. Labcorp Mycoplasma Testing in Clinical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Labcorp Mycoplasma Testing in Clinical Product Portfolio Table 66. Labcorp Recent Development Table 67. IDEXX BioAnalytics Company Information Table 68. IDEXX BioAnalytics Business Overview Table 69. IDEXX BioAnalytics Mycoplasma Testing in Clinical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. IDEXX BioAnalytics Mycoplasma Testing in Clinical Product Portfolio Table 71. IDEXX BioAnalytics Recent Development Table 72. WiCell Company Information Table 73. WiCell Business Overview Table 74. WiCell Mycoplasma Testing in Clinical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. WiCell Mycoplasma Testing in Clinical Product Portfolio Table 76. WiCell Recent Development Table 77. Creative Biogene Company Information Table 78. Creative Biogene Business Overview Table 79. Creative Biogene Mycoplasma Testing in Clinical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Creative Biogene Mycoplasma Testing in Clinical Product Portfolio Table 81. Creative Biogene Recent Development Table 82. Eurofins Scientific Company Information Table 83. Eurofins Scientific Business Overview Table 84. Eurofins Scientific Mycoplasma Testing in Clinical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Eurofins Scientific Mycoplasma Testing in Clinical Product Portfolio Table 86. Eurofins Scientific Recent Development Table 87. Hylabs Company Information Table 88. Hylabs Business Overview Table 89. Hylabs Mycoplasma Testing in Clinical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 90. Hylabs Mycoplasma Testing in Clinical Product Portfolio Table 91. Hylabs Recent Development Table 92. JOINN Laboratories Company Information Table 93. JOINN Laboratories Business Overview Table 94. JOINN Laboratories Mycoplasma Testing in Clinical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 95. JOINN Laboratories Mycoplasma Testing in Clinical Product Portfolio Table 96. JOINN Laboratories Recent Development Table 97. Shimadzu Diagnostics Company Information Table 98. Shimadzu Diagnostics Business Overview Table 99. Shimadzu Diagnostics Mycoplasma Testing in Clinical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 100. Shimadzu Diagnostics Mycoplasma Testing in Clinical Product Portfolio Table 101. Shimadzu Diagnostics Recent Development Table 102. CellSafe Company Information Table 103. CellSafe Business Overview Table 104. CellSafe Mycoplasma Testing in Clinical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 105. CellSafe Mycoplasma Testing in Clinical Product Portfolio Table 106. CellSafe Recent Development Table 107. FullHope Biomedical Company Information Table 108. FullHope Biomedical Business Overview Table 109. FullHope Biomedical Mycoplasma Testing in Clinical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 110. FullHope Biomedical Mycoplasma Testing in Clinical Product Portfolio Table 111. FullHope Biomedical Recent Development Table 112. Syngene International Company Information Table 113. Syngene International Business Overview Table 114. Syngene International Mycoplasma Testing in Clinical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 115. Syngene International Mycoplasma Testing in Clinical Product Portfolio Table 116. Syngene International Recent Development Table 117. Beyotime Company Information Table 118. Beyotime Business Overview Table 119. Beyotime Mycoplasma Testing in Clinical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 120. Beyotime Mycoplasma Testing in Clinical Product Portfolio Table 121. Beyotime Recent Development Table 122. CTI Cert Company Information Table 123. CTI Cert Business Overview Table 124. CTI Cert Mycoplasma Testing in Clinical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 125. CTI Cert Mycoplasma Testing in Clinical Product Portfolio Table 126. CTI Cert Recent Development Table 127. Shenke Bio Company Information Table 128. Shenke Bio Business Overview Table 129. Shenke Bio Mycoplasma Testing in Clinical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 130. Shenke Bio Mycoplasma Testing in Clinical Product Portfolio Table 131. Shenke Bio Recent Development Table 132. North America Mycoplasma Testing in Clinical Market Size by Type (2021-2026) & (US$ Million) Table 133. North America Mycoplasma Testing in Clinical Market Size by Type (2027-2032) & (US$ Million) Table 134. North America Mycoplasma Testing in Clinical Market Size by Application (2021-2026) & (US$ Million) Table 135. North America Mycoplasma Testing in Clinical Market Size by Application (2027-2032) & (US$ Million) Table 136. North America Mycoplasma Testing in Clinical Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 137. North America Mycoplasma Testing in Clinical Market Size by Country (2021-2026) Table 138. North America Mycoplasma Testing in Clinical Market Size by Country (2027-2032) Table 139. Europe Mycoplasma Testing in Clinical Market Size by Type (2021-2026) & (US$ Million) Table 140. Europe Mycoplasma Testing in Clinical Market Size by Type (2027-2032) & (US$ Million) Table 141. Europe Mycoplasma Testing in Clinical Market Size by Application (2021-2026) & (US$ Million) Table 142. Europe Mycoplasma Testing in Clinical Market Size by Application (2027-2032) & (US$ Million) Table 143. Europe Mycoplasma Testing in Clinical Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 144. Europe Mycoplasma Testing in Clinical Market Size by Country (2021-2026) Table 145. Europe Mycoplasma Testing in Clinical Market Size by Country (2027-2032) Table 146. China Mycoplasma Testing in Clinical Market Size by Type (2021-2026) & (US$ Million) Table 147. China Mycoplasma Testing in Clinical Market Size by Type (2027-2032) & (US$ Million) Table 148. China Mycoplasma Testing in Clinical Market Size by Application (2021-2026) & (US$ Million) Table 149. China Mycoplasma Testing in Clinical Market Size by Application (2027-2032) & (US$ Million) Table 150. Asia Mycoplasma Testing in Clinical Market Size by Type (2021-2026) & (US$ Million) Table 151. Asia Mycoplasma Testing in Clinical Market Size by Type (2027-2032) & (US$ Million) Table 152. Asia Mycoplasma Testing in Clinical Market Size by Application (2021-2026) & (US$ Million) Table 153. Asia Mycoplasma Testing in Clinical Market Size by Application (2027-2032) & (US$ Million) Table 154. Asia Mycoplasma Testing in Clinical Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 155. Asia Mycoplasma Testing in Clinical Market Size by Country (2021-2026) Table 156. Asia Mycoplasma Testing in Clinical Market Size by Country (2027-2032) Table 157. South America, Middle East & Africa Mycoplasma Testing in Clinical Market Size by Type (2021-2026) & (US$ Million) Table 158. South America, Middle East & Africa Mycoplasma Testing in Clinical Market Size by Type (2027-2032) & (US$ Million) Table 159. South America, Middle East & Africa Mycoplasma Testing in Clinical Market Size by Application (2021-2026) & (US$ Million) Table 160. South America, Middle East & Africa Mycoplasma Testing in Clinical Market Size by Application (2027-2032) & (US$ Million) Table 161. South America, Middle East & Africa Mycoplasma Testing in Clinical Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 162. South America, Middle East & Africa Mycoplasma Testing in Clinical Market Size by Country (2021-2026) Table 163. South America, Middle East & Africa Mycoplasma Testing in Clinical Market Size by Country (2027-2032) Table 164. Research Programs/Design for This Report Table 165. Authors List of This Report Table 166. Secondary Sources Table 167. Primary Sources List of Figures Figure 1. Mycoplasma Testing in Clinical Product Image Figure 2. Global Mycoplasma Testing in Clinical Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Mycoplasma Testing in Clinical Market Share by Type: 2025 VS 2032 Figure 4. Culture-based Mycoplasma Detection Image Figure 5. PCR/qPCR Mycoplasma Detection Image Figure 6. Others Image Figure 7. Global Mycoplasma Testing in Clinical Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Mycoplasma Testing in Clinical Market Share by Application: 2025 VS 2032 Figure 9. Hospitals Image Figure 10. Clinical Laboratories Image Figure 11. Public Health Institutions Image Figure 12. Third-Party Medical Testing Centers Image Figure 13. Others Image Figure 14. Global Mycoplasma Testing in Clinical Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Mycoplasma Testing in Clinical Market Size (2021-2032) & (US$ Million) Figure 16. Global Mycoplasma Testing in Clinical Market Share by Region: 2025 VS 2032 Figure 17. Years Considered Figure 18. Global Mycoplasma Testing in Clinical Market Share by Players in 2025 Figure 19. Global Top 5 and 10 Mycoplasma Testing in Clinical Players Market Share by Revenue in 2025 Figure 20. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Mycoplasma Testing in Clinical Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Mycoplasma Testing in Clinical Revenue Market Share by Type (2021-2032) Figure 23. Global Mycoplasma Testing in Clinical Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Mycoplasma Testing in Clinical Revenue Market Share by Application (2021-2032) Figure 25. North America Mycoplasma Testing in Clinical Market Size (2021-2032) & (US$ Million) Figure 26. North America Mycoplasma Testing in Clinical Market Share by Type (2021-2032) Figure 27. North America Mycoplasma Testing in Clinical Market Share by Application (2021-2032) Figure 28. North America Mycoplasma Testing in Clinical Market Share by Country (2021-2032) Figure 29. United States Mycoplasma Testing in Clinical Market Size (2021-2032) & (US$ Million) Figure 30. Canada Mycoplasma Testing in Clinical Market Size (2021-2032) & (US$ Million) Figure 31. Mexico Mycoplasma Testing in Clinical Market Size (2021-2032) & (US$ Million) Figure 32. Europe Mycoplasma Testing in Clinical Market Size (2021-2032) & (US$ Million) Figure 33. Europe Mycoplasma Testing in Clinical Market Share by Type (2021-2032) Figure 34. Europe Mycoplasma Testing in Clinical Market Share by Application (2021-2032) Figure 35. Europe Mycoplasma Testing in Clinical Market Share by Country (2021-2032) Figure 36. Germany Mycoplasma Testing in Clinical Market Size (2021-2032) & (US$ Million) Figure 37. France Mycoplasma Testing in Clinical Market Size (2021-2032) & (US$ Million) Figure 38. U.K. Mycoplasma Testing in Clinical Market Size (2021-2032) & (US$ Million) Figure 39. Italy Mycoplasma Testing in Clinical Market Size (2021-2032) & (US$ Million) Figure 40. Russia Mycoplasma Testing in Clinical Market Size (2021-2032) & (US$ Million) Figure 41. Nordic Countries Mycoplasma Testing in Clinical Market Size (2021-2032) & (US$ Million) Figure 42. China Mycoplasma Testing in Clinical Market Size (2021-2032) & (US$ Million) Figure 43. China Mycoplasma Testing in Clinical Market Share by Type (2021-2032) Figure 44. China Mycoplasma Testing in Clinical Market Share by Application (2021-2032) Figure 45. Asia Mycoplasma Testing in Clinical Market Size (2021-2032) & (US$ Million) Figure 46. Asia Mycoplasma Testing in Clinical Market Share by Type (2021-2032) Figure 47. Asia Mycoplasma Testing in Clinical Market Share by Application (2021-2032) Figure 48. Asia Mycoplasma Testing in Clinical Market Share by Country (2021-2032) Figure 49. Japan Mycoplasma Testing in Clinical Market Size (2021-2032) & (US$ Million) Figure 50. South Korea Mycoplasma Testing in Clinical Market Size (2021-2032) & (US$ Million) Figure 51. Taiwan Mycoplasma Testing in Clinical Market Size (2021-2032) & (US$ Million) Figure 52. Southeast Asia Mycoplasma Testing in Clinical Market Size (2021-2032) & (US$ Million) Figure 53. India Mycoplasma Testing in Clinical Market Size (2021-2032) & (US$ Million) Figure 54. Australia Mycoplasma Testing in Clinical Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Mycoplasma Testing in Clinical Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Mycoplasma Testing in Clinical Market Share by Type (2021-2032) Figure 57. South America, Middle East & Africa Mycoplasma Testing in Clinical Market Share by Application (2021-2032) Figure 58. South America, Middle East & Africa Mycoplasma Testing in Clinical Market Share by Country (2021-2032) Figure 59. Brazil Mycoplasma Testing in Clinical Market Size (2021-2032) & (US$ Million) Figure 60. South Africa Mycoplasma Testing in Clinical Market Size (2021-2032) & (US$ Million) Figure 61. Saudi Arabia Mycoplasma Testing in Clinical Market Size (2021-2032) & (US$ Million) Figure 62. Turkey Mycoplasma Testing in Clinical Market Size (2021-2032) & (US$ Million) Figure 63. Argentina Mycoplasma Testing in Clinical Market Size (2021-2032) & (US$ Million) Figure 64. UAE Mycoplasma Testing in Clinical Market Size (2021-2032) & (US$ Million) Figure 65. Egypt Mycoplasma Testing in Clinical Market Size (2021-2032) & (US$ Million) Figure 66. Chile Mycoplasma Testing in Clinical Market Size (2021-2032) & (US$ Million) Figure 67. Research Process Figure 68. Key Executives Interviewed

Scope & coverage.

Types
  • Culture-based Mycoplasma Detection
  • PCR/qPCR Mycoplasma Detection
  • Others
Applications
  • Hospitals
  • Clinical Laboratories
  • Public Health Institutions
  • Third-Party Medical Testing Centers
  • Others
Companies covered
  • Charles River Laboratories International
  • Thermo Fisher Scientific
  • SGS
  • Bionique Testing Laboratories
  • WuXi AppTec
  • Labcorp
  • IDEXX BioAnalytics
  • WiCell
  • Creative Biogene
  • Eurofins Scientific
  • Hylabs
  • JOINN Laboratories
  • Shimadzu Diagnostics
  • CellSafe
  • FullHope Biomedical
  • Syngene International
  • Beyotime
  • CTI Cert
  • Shenke Bio

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Mycoplasma Testing in Clinical Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Culture-based Mycoplasma Detection
  5. 1.2.3 PCR/qPCR Mycoplasma Detection
  6. 1.2.4 Others
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Mycoplasma Testing in Clinical Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Hospitals
  10. 1.3.3 Clinical Laboratories
  11. 1.3.4 Public Health Institutions
  12. 1.3.5 Third-Party Medical Testing Centers
  13. 1.3.6 Others
  14. 1.4 Global Market Growth Prospects
  15. 1.5 Global Mycoplasma Testing in Clinical Growth Trends by Region
  16. 1.5.1 Global Mycoplasma Testing in Clinical Market Size by Region: 2021 VS 2025 VS 2032
  17. 1.5.2 Mycoplasma Testing in Clinical Market Size by Region (2021-2026)
  18. 1.5.3 Mycoplasma Testing in Clinical Market Size by Region (2027-2032)
  19. 1.6 Assumptions and Limitations
  20. 1.7 Study Goals and Objectives
  21. 1.8 Years Considered
2 Global Mycoplasma Testing in Clinical Market Dynamics
  1. 2.1 Mycoplasma Testing in Clinical Industry Trends
  2. 2.2 Mycoplasma Testing in Clinical Industry Drivers
  3. 2.3 Mycoplasma Testing in Clinical Industry Opportunities and Challenges
  4. 2.4 Mycoplasma Testing in Clinical Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Mycoplasma Testing in Clinical Revenue by Company (2021-2026)
  2. 3.2 Global Mycoplasma Testing in Clinical Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Mycoplasma Testing in Clinical Key Company Head office and Area Served
  4. 3.4 Global Mycoplasma Testing in Clinical Company, Product Type & Application
  5. 3.5 Global Mycoplasma Testing in Clinical Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Mycoplasma Testing in Clinical Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Mycoplasma Testing in Clinical Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Mycoplasma Testing in Clinical Tier 1, Tier 2, and Tier 3
4 Mycoplasma Testing in Clinical Market by Type
  1. 4.1 Global Mycoplasma Testing in Clinical Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Mycoplasma Testing in Clinical Market Size by Type (2021-2032)
  3. 4.3 Global Mycoplasma Testing in Clinical Market Size Share by Type (2021-2032)
5 Mycoplasma Testing in Clinical Market by Application
  1. 5.1 Global Mycoplasma Testing in Clinical Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Mycoplasma Testing in Clinical Market Size by Application (2021-2032)
  3. 5.3 Global Mycoplasma Testing in Clinical Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Charles River Laboratories International
  2. 6.1.1 Charles River Laboratories International Company Information
  3. 6.1.2 Charles River Laboratories International Business Overview
  4. 6.1.3 Charles River Laboratories International Mycoplasma Testing in Clinical Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Charles River Laboratories International Mycoplasma Testing in Clinical Product Portfolio
  6. 6.1.5 Charles River Laboratories International Recent Developments
  7. 6.2 Thermo Fisher Scientific
  8. 6.2.1 Thermo Fisher Scientific Company Information
  9. 6.2.2 Thermo Fisher Scientific Business Overview
  10. 6.2.3 Thermo Fisher Scientific Mycoplasma Testing in Clinical Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Thermo Fisher Scientific Mycoplasma Testing in Clinical Product Portfolio
  12. 6.2.5 Thermo Fisher Scientific Recent Developments
  13. 6.3 SGS
  14. 6.3.1 SGS Company Information
  15. 6.3.2 SGS Business Overview
  16. 6.3.3 SGS Mycoplasma Testing in Clinical Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 SGS Mycoplasma Testing in Clinical Product Portfolio
  18. 6.3.5 SGS Recent Developments
  19. 6.4 Bionique Testing Laboratories
  20. 6.4.1 Bionique Testing Laboratories Company Information
  21. 6.4.2 Bionique Testing Laboratories Business Overview
  22. 6.4.3 Bionique Testing Laboratories Mycoplasma Testing in Clinical Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Bionique Testing Laboratories Mycoplasma Testing in Clinical Product Portfolio
  24. 6.4.5 Bionique Testing Laboratories Recent Developments
  25. 6.5 WuXi AppTec
  26. 6.5.1 WuXi AppTec Company Information
  27. 6.5.2 WuXi AppTec Business Overview
  28. 6.5.3 WuXi AppTec Mycoplasma Testing in Clinical Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 WuXi AppTec Mycoplasma Testing in Clinical Product Portfolio
  30. 6.5.5 WuXi AppTec Recent Developments
  31. 6.6 Labcorp
  32. 6.6.1 Labcorp Company Information
  33. 6.6.2 Labcorp Business Overview
  34. 6.6.3 Labcorp Mycoplasma Testing in Clinical Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Labcorp Mycoplasma Testing in Clinical Product Portfolio
  36. 6.6.5 Labcorp Recent Developments
  37. 6.7 IDEXX BioAnalytics
  38. 6.7.1 IDEXX BioAnalytics Company Information
  39. 6.7.2 IDEXX BioAnalytics Business Overview
  40. 6.7.3 IDEXX BioAnalytics Mycoplasma Testing in Clinical Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 IDEXX BioAnalytics Mycoplasma Testing in Clinical Product Portfolio
  42. 6.7.5 IDEXX BioAnalytics Recent Developments
  43. 6.8 WiCell
  44. 6.8.1 WiCell Company Information
  45. 6.8.2 WiCell Business Overview
  46. 6.8.3 WiCell Mycoplasma Testing in Clinical Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 WiCell Mycoplasma Testing in Clinical Product Portfolio
  48. 6.8.5 WiCell Recent Developments
  49. 6.9 Creative Biogene
  50. 6.9.1 Creative Biogene Company Information
  51. 6.9.2 Creative Biogene Business Overview
  52. 6.9.3 Creative Biogene Mycoplasma Testing in Clinical Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Creative Biogene Mycoplasma Testing in Clinical Product Portfolio
  54. 6.9.5 Creative Biogene Recent Developments
  55. 6.10 Eurofins Scientific
  56. 6.10.1 Eurofins Scientific Company Information
  57. 6.10.2 Eurofins Scientific Business Overview
  58. 6.10.3 Eurofins Scientific Mycoplasma Testing in Clinical Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Eurofins Scientific Mycoplasma Testing in Clinical Product Portfolio
  60. 6.10.5 Eurofins Scientific Recent Developments
  61. 6.11 Hylabs
  62. 6.11.1 Hylabs Company Information
  63. 6.11.2 Hylabs Business Overview
  64. 6.11.3 Hylabs Mycoplasma Testing in Clinical Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Hylabs Mycoplasma Testing in Clinical Product Portfolio
  66. 6.11.5 Hylabs Recent Developments
  67. 6.12 JOINN Laboratories
  68. 6.12.1 JOINN Laboratories Company Information
  69. 6.12.2 JOINN Laboratories Business Overview
  70. 6.12.3 JOINN Laboratories Mycoplasma Testing in Clinical Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 JOINN Laboratories Mycoplasma Testing in Clinical Product Portfolio
  72. 6.12.5 JOINN Laboratories Recent Developments
  73. 6.13 Shimadzu Diagnostics
  74. 6.13.1 Shimadzu Diagnostics Company Information
  75. 6.13.2 Shimadzu Diagnostics Business Overview
  76. 6.13.3 Shimadzu Diagnostics Mycoplasma Testing in Clinical Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Shimadzu Diagnostics Mycoplasma Testing in Clinical Product Portfolio
  78. 6.13.5 Shimadzu Diagnostics Recent Developments
  79. 6.14 CellSafe
  80. 6.14.1 CellSafe Company Information
  81. 6.14.2 CellSafe Business Overview
  82. 6.14.3 CellSafe Mycoplasma Testing in Clinical Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 CellSafe Mycoplasma Testing in Clinical Product Portfolio
  84. 6.14.5 CellSafe Recent Developments
  85. 6.15 FullHope Biomedical
  86. 6.15.1 FullHope Biomedical Company Information
  87. 6.15.2 FullHope Biomedical Business Overview
  88. 6.15.3 FullHope Biomedical Mycoplasma Testing in Clinical Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 FullHope Biomedical Mycoplasma Testing in Clinical Product Portfolio
  90. 6.15.5 FullHope Biomedical Recent Developments
  91. 6.16 Syngene International
  92. 6.16.1 Syngene International Company Information
  93. 6.16.2 Syngene International Business Overview
  94. 6.16.3 Syngene International Mycoplasma Testing in Clinical Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Syngene International Mycoplasma Testing in Clinical Product Portfolio
  96. 6.16.5 Syngene International Recent Developments
  97. 6.17 Beyotime
  98. 6.17.1 Beyotime Company Information
  99. 6.17.2 Beyotime Business Overview
  100. 6.17.3 Beyotime Mycoplasma Testing in Clinical Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Beyotime Mycoplasma Testing in Clinical Product Portfolio
  102. 6.17.5 Beyotime Recent Developments
  103. 6.18 CTI Cert
  104. 6.18.1 CTI Cert Company Information
  105. 6.18.2 CTI Cert Business Overview
  106. 6.18.3 CTI Cert Mycoplasma Testing in Clinical Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 CTI Cert Mycoplasma Testing in Clinical Product Portfolio
  108. 6.18.5 CTI Cert Recent Developments
  109. 6.19 Shenke Bio
  110. 6.19.1 Shenke Bio Company Information
  111. 6.19.2 Shenke Bio Business Overview
  112. 6.19.3 Shenke Bio Mycoplasma Testing in Clinical Revenue and Gross Margin (US$ Million) & (2021-2026)
  113. 6.19.4 Shenke Bio Mycoplasma Testing in Clinical Product Portfolio
  114. 6.19.5 Shenke Bio Recent Developments
7 North America
  1. 7.1 North America Mycoplasma Testing in Clinical Market Size (2021-2032)
  2. 7.2 North America Mycoplasma Testing in Clinical Market Size by Type
  3. 7.2.1 North America Mycoplasma Testing in Clinical Market Size by Type (2021-2026)
  4. 7.2.2 North America Mycoplasma Testing in Clinical Market Size by Type (2027-2032)
  5. 7.2.3 North America Mycoplasma Testing in Clinical Market Share by Type (2021-2032)
  6. 7.3 North America Mycoplasma Testing in Clinical Market Size by Application
  7. 7.3.1 North America Mycoplasma Testing in Clinical Market Size by Application (2021-2026)
  8. 7.3.2 North America Mycoplasma Testing in Clinical Market Size by Application (2027-2032)
  9. 7.3.3 North America Mycoplasma Testing in Clinical Market Share by Application (2021-2032)
  10. 7.4 North America Mycoplasma Testing in Clinical Market Size by Country
  11. 7.4.1 North America Mycoplasma Testing in Clinical Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Mycoplasma Testing in Clinical Market Size by Country (2021-2026)
  13. 7.4.3 North America Mycoplasma Testing in Clinical Market Size by Country (2027-2032)
  14. 7.4.4 North America Mycoplasma Testing in Clinical Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Mycoplasma Testing in Clinical Market Size (2021-2032)
  2. 8.2 Europe Mycoplasma Testing in Clinical Market Size by Type
  3. 8.2.1 Europe Mycoplasma Testing in Clinical Market Size by Type (2021-2026)
  4. 8.2.2 Europe Mycoplasma Testing in Clinical Market Size by Type (2027-2032)
  5. 8.2.3 Europe Mycoplasma Testing in Clinical Market Share by Type (2021-2032)
  6. 8.3 Europe Mycoplasma Testing in Clinical Market Size by Application
  7. 8.3.1 Europe Mycoplasma Testing in Clinical Market Size by Application (2021-2026)
  8. 8.3.2 Europe Mycoplasma Testing in Clinical Market Size by Application (2027-2032)
  9. 8.3.3 Europe Mycoplasma Testing in Clinical Market Share by Application (2021-2032)
  10. 8.4 Europe Mycoplasma Testing in Clinical Market Size by Country
  11. 8.4.1 Europe Mycoplasma Testing in Clinical Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Mycoplasma Testing in Clinical Market Size by Country (2021-2026)
  13. 8.4.3 Europe Mycoplasma Testing in Clinical Market Size by Country (2027-2032)
  14. 8.4.4 Europe Mycoplasma Testing in Clinical Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Mycoplasma Testing in Clinical Market Size (2021-2032)
  2. 9.2 China Mycoplasma Testing in Clinical Market Size by Type
  3. 9.2.1 China Mycoplasma Testing in Clinical Market Size by Type (2021-2026)
  4. 9.2.2 China Mycoplasma Testing in Clinical Market Size by Type (2027-2032)
  5. 9.2.3 China Mycoplasma Testing in Clinical Market Share by Type (2021-2032)
  6. 9.3 China Mycoplasma Testing in Clinical Market Size by Application
  7. 9.3.1 China Mycoplasma Testing in Clinical Market Size by Application (2021-2026)
  8. 9.3.2 China Mycoplasma Testing in Clinical Market Size by Application (2027-2032)
  9. 9.3.3 China Mycoplasma Testing in Clinical Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Mycoplasma Testing in Clinical Market Size (2021-2032)
  2. 10.2 Asia Mycoplasma Testing in Clinical Market Size by Type
  3. 10.2.1 Asia Mycoplasma Testing in Clinical Market Size by Type (2021-2026)
  4. 10.2.2 Asia Mycoplasma Testing in Clinical Market Size by Type (2027-2032)
  5. 10.2.3 Asia Mycoplasma Testing in Clinical Market Share by Type (2021-2032)
  6. 10.3 Asia Mycoplasma Testing in Clinical Market Size by Application
  7. 10.3.1 Asia Mycoplasma Testing in Clinical Market Size by Application (2021-2026)
  8. 10.3.2 Asia Mycoplasma Testing in Clinical Market Size by Application (2027-2032)
  9. 10.3.3 Asia Mycoplasma Testing in Clinical Market Share by Application (2021-2032)
  10. 10.4 Asia Mycoplasma Testing in Clinical Market Size by Country
  11. 10.4.1 Asia Mycoplasma Testing in Clinical Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Mycoplasma Testing in Clinical Market Size by Country (2021-2026)
  13. 10.4.3 Asia Mycoplasma Testing in Clinical Market Size by Country (2027-2032)
  14. 10.4.4 Asia Mycoplasma Testing in Clinical Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Mycoplasma Testing in Clinical Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Mycoplasma Testing in Clinical Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Mycoplasma Testing in Clinical Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Mycoplasma Testing in Clinical Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Mycoplasma Testing in Clinical Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Mycoplasma Testing in Clinical Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Mycoplasma Testing in Clinical Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Mycoplasma Testing in Clinical Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Mycoplasma Testing in Clinical Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Mycoplasma Testing in Clinical Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Mycoplasma Testing in Clinical Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Mycoplasma Testing in Clinical Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Mycoplasma Testing in Clinical Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Mycoplasma Testing in Clinical Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst